Lincoln Pharmaceuticals consolidated net profit rises 37.70% in the December 2025 quarter
Sales rise 13.49% to Rs 166.32 crore
Net profit of Lincoln Pharmaceuticals rose 37.70% to Rs 28.60 crore in the quarter ended December 2025 as against Rs 20.77 crore during the previous quarter ended December 2024. Sales rose 13.49% to Rs 166.32 crore in the quarter ended December 2025 as against Rs 146.55 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales166.32146.55 13 OPM %14.1816.14 -PBDT38.4431.91 20 PBT34.7228.68 21 NP28.6020.77 38Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 12 2026 | 1:05 PM IST